...
首页> 外文期刊>Journal of Neuroimmunology: Official Bulletin of the Research Committee on Neuroimmunology of the World Federation of Neurology >An IgM anti-MBP Ab in a case of Waldenstrom's macroglobulinemia with polyneuropathy expressing an idiotype reactive with an MBP epitope immunodominant in MS and EAE.
【24h】

An IgM anti-MBP Ab in a case of Waldenstrom's macroglobulinemia with polyneuropathy expressing an idiotype reactive with an MBP epitope immunodominant in MS and EAE.

机译:在患有多发性神经病的Waldenstrom巨球蛋白血症的情况下,IgM抗MBP Ab表现出与MS和EAE中以免疫为主的MBP表位反应的独特型。

获取原文
获取原文并翻译 | 示例
           

摘要

In a previously described case of Waldenstrom's Macroglobulinemia, complicated by polyneuropathy, the IgM/lambda monoclonal antibody (mAb) was highly reactive with myelin basic protein (MBP). Given our demonstration that V lambda x, a recently described murine lambda variable region gene product, can itself bind MBP as well as confer MBP reactivity to an Ab, the possibility of a shared idiotypy between murine V lambda x and this human IgM/lambda anti-MBP was investigated. We characterized the epitope specificity of the macroglobulinemia patient's MBP-reactive IgM/lambda using indirect ELISA procedures with MBP, a citrullinated isomer of MBP termed C8, or peptide fragments of MBP as the coating antigens and monospecific Ab to V lambda x as the secondary Ab. The patient's MBP-reactive IgM/lambda was recognized by Ab specific for V lambda x and, like murine mAb containing V lambda x bound human MBP but not MBP-C8 nor other common autoantigens such as DNA, thyroglobulin, or actin. The anti-MBP reactivity was selective for MBP peptide 90-170 and preferentially recognized MBP peptide 84-96. Thus, the patient's macroglobulin and perhaps certain other human Ab with a 'V lambda x idiotype' bind to MBP peptide residues 84-96, an immunodominant peptide in multiple sclerosis patients. Such binding may be involved in the pathogenesis of neural damage in patients with neuroimmunologic disorders related to plasma cell dyscrasias or autoimmunity.
机译:在先前描述的Waldenstrom巨球蛋白血症并发多发性神经病的情况下,IgM /λ单克隆抗体(mAb)与髓磷脂碱性蛋白(MBP)高度反应。鉴于我们的证明,V lambda x(一种最近描述的鼠lambda可变区基因产物)本身可以结合MBP并赋予MBP与Ab的反应性,因此鼠v lambda x与该人IgM / lambda anti -MBP进行了调查。我们使用间接ELISA程序,使用MBP,MBP的瓜氨酸异构体(称为C8)或MBP的肽片段作为包被抗原,将单特异性抗体至Vλx作为次要抗体,来表征大球蛋白血症患者的MBP反应性IgM / lambda的表位特异性。患者的MBP反应性IgM /λ被Vλ特异的Ab识别,例如含有Vλx的鼠单克隆抗体结合了人MBP,但不结合MBP-C8或其他常见的自身抗原,例如DNA,甲状腺球蛋白或肌动蛋白。抗MBP反应性对MBP肽90-170和优先识别的MBP肽84-96具有选择性。因此,患者的巨球蛋白和某些其他具有“ V lambda x独特型”的人类抗体与MBP肽残基84-96结合,MBP肽残基是多发性硬化症患者的一种免疫优势肽。这种结合可能与患有与浆细胞异常或自身免疫有关的神经免疫疾病患者的神经损伤的发病机制有关。

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号